- Home
- AIRI vs XAIR Comparison
AIRI vs XAIR Comparison
Compare AIRI & XAIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIRI
- XAIR
- Stock Information
- Founded
- AIRI 1979
- XAIR 2011
- Country
- AIRI United States
- XAIR United States
- Employees
- AIRI N/A
- XAIR N/A
- Industry
- AIRI Military/Government/Technical
- XAIR Medical/Dental Instruments
- Sector
- AIRI Industrials
- XAIR Health Care
- Exchange
- AIRI Nasdaq
- XAIR Nasdaq
- Market Cap
- AIRI 15.2M
- XAIR 17.0M
- IPO Year
- AIRI N/A
- XAIR N/A
- Fundamental
- Price
- AIRI $3.17
- XAIR $2.47
- Analyst Decision
- AIRI
- XAIR Strong Buy
- Analyst Count
- AIRI 0
- XAIR 1
- Target Price
- AIRI N/A
- XAIR $11.00
- AVG Volume (30 Days)
- AIRI 43.2K
- XAIR 466.2K
- Earning Date
- AIRI 11-13-2025
- XAIR 11-10-2025
- Dividend Yield
- AIRI N/A
- XAIR N/A
- EPS Growth
- AIRI N/A
- XAIR N/A
- EPS
- AIRI N/A
- XAIR N/A
- Revenue
- AIRI $52,277,000.00
- XAIR $4,782,000.00
- Revenue This Year
- AIRI N/A
- XAIR $263.75
- Revenue Next Year
- AIRI $3.53
- XAIR $148.43
- P/E Ratio
- AIRI N/A
- XAIR N/A
- Revenue Growth
- AIRI N/A
- XAIR 168.20
- 52 Week Low
- AIRI $2.80
- XAIR $2.02
- 52 Week High
- AIRI $6.41
- XAIR $13.52
- Technical
- Relative Strength Index (RSI)
- AIRI 52.72
- XAIR 53.79
- Support Level
- AIRI $3.03
- XAIR $2.31
- Resistance Level
- AIRI $3.18
- XAIR $2.53
- Average True Range (ATR)
- AIRI 0.10
- XAIR 0.12
- MACD
- AIRI 0.01
- XAIR 0.01
- Stochastic Oscillator
- AIRI 72.92
- XAIR 82.43
About AIRI Air Industries Group
Air Industries Group is an aerospace and defense company. Its manufactures and designs structural parts and assemblies that focus on flight safety, including landing gear, arresting gear, engine mounts, flight controls, throttle quadrants, jet engines, and other components. The company also provides sheet metal fabrication of aerostructures, tube bending, and welding services.
About XAIR Beyond Air Inc.
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.